Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1995;73(2):191–197.

Treatment of Mediterranean visceral leishmaniasis.

L Gradoni 1, A Bryceson 1, P Desjeux 1
PMCID: PMC2486749  PMID: 7743590

Abstract

Up-to-date information is given on the epidemiological situation of zoonotic visceral leishmaniasis (ZVL) in nine Mediterranean countries, and on drug regimens adopted in the management of ZVL patients in each country. Results of experimental and clinical trials on the efficacy and tolerability of liposomal amphotericin B in laboratory animals and in patients with ZVL are presented, as well as conclusions and recommendations on drug regimens to be used in the treatment of ZVL.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvar J., Gutiérrez-Solar B., Molina R., López-Velez R., Garcia-Camacho A., Martinez P., Laguna F., Cercenado E., Galmes A. Prevalence of Leishmania infection among AIDS patients. Lancet. 1992 Jun 6;339(8806):1427–1427. doi: 10.1016/0140-6736(92)91255-7. [DOI] [PubMed] [Google Scholar]
  2. Davidson R. N., Croft S. L., Scott A., Maini M., Moody A. H., Bryceson A. D. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet. 1991 May 4;337(8749):1061–1062. doi: 10.1016/0140-6736(91)91708-3. [DOI] [PubMed] [Google Scholar]
  3. Giacchino R., Giambartolomei G., Tasso L., Timitilli A., Castagnola E., Brisigotti M., Micalizzi C. Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1993 May-Jun;87(3):310–310. doi: 10.1016/0035-9203(93)90141-c. [DOI] [PubMed] [Google Scholar]
  4. Gradoni L., Pizzuti R., di Martino L., Gramiccia M., Pempinello R., Gaeta G. B., Ferrara M., Scotti S., Altieri S. The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing. Epidemiol Infect. 1993 Oct;111(2):297–306. doi: 10.1017/s0950268800057009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Olliaro P. L., Bryceson A. D. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today. 1993 Sep;9(9):323–328. doi: 10.1016/0169-4758(93)90231-4. [DOI] [PubMed] [Google Scholar]
  6. di Martino L., Raimondi F., Scotti S., Davidson R. N., Gradoni L., Giacchino R. Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):477–477. doi: 10.1016/0035-9203(93)90045-r. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES